mitoguazone

DRUG2 trials

Sponsors

Genzyme, a Sanofi Company, French Innovative Leukemia Organisation

Conditions

HIV InfectionsLymphomaLymphoma, Non-Hodgkin

Phase 2

A Study of Mitoguazone Dihydrochloride in Patients With AIDS-Related Non-Hodgkin's Lymphoma

CompletedNCT00002348

Genzyme, a Sanofi CompanyHIV Infections, Lymphoma, Non-Hodgkin

Updated: 2020-12-19

Phase 3

Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma

TerminatedNCT00920153

French Innovative Leukemia OrganisationLymphoma

Start: 2008-05-31End: 2016-03-31Updated: 2016-09-16

Related Papers

Interim PET Response-adapted Strategy in Untreated Advanced Stage Hodgkin Lymphoma: Results of GOELAMS LH 2007 Phase 2 Multicentric Trial.

2018-01-315 citations

PET Adapted Salvage Therapy for Advanced Hodgkin Lymphomas: Towards the Suppression of Positive Interim PET Unfavorable Prognosis? a Report of the Goelams Multicentric Phase 2 Trial LH2007

Blood2015-12-03